Scenic Biotech
4 known investors
Scenic Biotech develops disease-modifying therapies for patients with neurological and metabolic genetic disorders using its Cell-Seq discovery platform to identify modifier genes. The company pursues "modifier therapy," which targets other genome functions that can neutralize disease impact rather than the primary disease-causing mutation.
Investors Β· 4
Frequently asked questions
- What does Scenic Biotech do?
- Scenic Biotech develops disease-modifying therapies for patients with neurological and metabolic genetic disorders using its Cell-Seq discovery platform to identify modifier genes. The company pursues "modifier therapy," which targets other genome functions that can neutralize disease impact rather than the primary disease-causing mutation.
- Who are Scenic Biotech's investors?
- Scenic Biotech's investors include BioMedPartners, EIR Ventures, Oxford Science Enterprises, Inkef.